TrialThe New England journal of medicine2017
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
Jedd D Wolchok et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2,010 papers cite itlatest 60 shown
this paperpooled ittrialcites it